AstraZeneca

AstraZeneca Wins This Summer's Pharma Acquisition Spree
Seeking Alpha
Sat, 08/18/12 - 04:03 pm
AstraZeneca
AstraZeneca Wins This Summer's Pharma Acquisition Spree
Seeking Alpha
Fri, 08/17/12 - 11:34 am
M&A
AstraZeneca
Bristol-Myers Squibb
JNJ
Verastem
Eli Lilly
Pfizer
The Men Who Run AstraZeneca
Motley Fool
Fri, 08/17/12 - 11:19 am
AstraZeneca
3 Big Reasons To Buy AstraZeneca Today
Seeking Alpha
Fri, 08/17/12 - 10:29 am
AstraZeneca
Eli Lilly
Novartis
GSK
Bristol-Myers Squibb
Alnylam, AstraZeneca form strategic alliance for microRNA
Yahoo/Fly on the Wall
Wed, 08/15/12 - 10:54 am
microRNA
Alnylam
AstraZeneca
Regulus
7 Big-Pharma Stocks With Untapped Potential
TheStreet.com
Tue, 08/14/12 - 11:07 am
GSK
JNJ
Bristol-Myers Squibb
Sanofi
AstraZeneca
Abbott Laboratories
Bayer
Novo Nordisk Still A Top-Notch Healthcare Growth Story
Seeking Alpha
Tue, 08/14/12 - 10:56 am
Novo Nordisk
AstraZeneca
Bristol-Myers Squibb
Sanofi
Eli Lilly
Pfizer paying AstraZeneca $250M for rights to nonprescription version of heartburn drug Nexium
Yahoo/AP
Tue, 08/14/12 - 10:54 am
Pfizer
AstraZeneca
Nexium
OTC
AstraZeneca buys equal say over Amylin drugs
Reuters
Thu, 08/9/12 - 10:56 am
Amylin
AstraZeneca
diabetes
Bristol-Myers Squibb
Pluristem's Cell Therapy For Bone Marrow A Blockbuster In The Making
Seeking Alpha
Wed, 08/8/12 - 12:04 pm
Pluristem
Amgen
AstraZeneca
Celgene
Dendreon
Eli Lilly
Medivation
Merck
Onyx
Pfizer
bone marrow disorder
Was MedImmune worth $15.6 billion?
Washington Post, DC
Mon, 08/6/12 - 11:44 am
MedImmune
AstraZeneca
The Cheapest, Dividend-Paying Major Drug Manufacturers
Seeking Alpha
Fri, 08/3/12 - 11:13 am
AstraZeneca
GSK
Eli Lilly
Sanofi
Vertex's Cystic Fibrosis Pipeline Offers Sales Upside
Seeking Alpha
Thu, 08/2/12 - 10:22 am
cystic fibrosis
Vertex Pharma
AstraZeneca
Gilead
Kalydeco
Pfizer
Rigel Pharmaceuticals
VX-809
Rigel's Drug Trials Offer Upside Through 2013
Seeking Alpha
Tue, 07/31/12 - 07:09 pm
Rigel Pharmaceuticals
Abbott Labs
Amgen
AstraZeneca
Roche Building On Its Strengths
Seeking Alpha
Mon, 07/30/12 - 11:44 am
Roche
Abbott Labs
AstraZeneca
Gilead
Complete Genomics
Sanofi
Pfizer
Pacific Biosciences
JNJ
Novartis
Illumina
GSK
Generics knock AstraZeneca Q2 earnings by 24 pct
Yahoo/AP
Thu, 07/26/12 - 09:24 am
earnings
AstraZeneca
A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Mon, 07/23/12 - 09:15 am
drug approvals
earnings
Amylin
InterMune
Human Genome Sciences
GSK
Bristol-Myers Squibb
Questcor
BiogenIdec
Alexion
Regeneron
Eli Lilly
Amarin
Horizon Pharma
Celgene
Amgen
Gilead
Alkermes
United Therapeutics
Roche
Sanofi
Merck
AstraZeneca
Salix
Progenics Pharmaceuticals
AstraZeneca backs $12M round for upstart's self-assembling drug pipeline
Fierce Biotech
Wed, 07/18/12 - 12:59 pm
AstraZeneca
MedImmune Ventures
Ascent Biomedical Ventures
Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now?
Seeking Alpha
Wed, 07/18/12 - 12:27 pm
Pluristem Therapeutics
Alkermes
AstraZeneca
Bristol-Myers Squibb
Isis Pharmaceuticals
Eli Lilly
Momenta
Merck
Pfizer
Sanofi
Spectrum Pharmaceuticals
AstraZeneca Expands Study Of Brilinta Against Plavix
Bloomberg
Tue, 07/17/12 - 10:47 am
AstraZeneca
Plavix
Brilinta
bloodthinners

Pages